Details for New Drug Application (NDA): 076105
✉ Email this page to a colleague
The generic ingredient in TRI-LEGEST FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 076105
Tradename: | TRI-LEGEST FE |
Applicant: | Barr |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 076105
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRI-LEGEST FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 076105 | ANDA | Teva Pharmaceuticals USA, Inc. | 0555-9032 | 0555-9032-70 | 5 BLISTER PACK in 1 CARTON (0555-9032-70) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG | ||||
Approval Date: | Oct 26, 2007 | TE: | AB | RLD: | No |
Complete Access Available with Subscription